Document is current
Any future updates will be listed below
-
Authors
Choi, Karmel W.
Stein, Murray B. https://orcid.org/0000-0001-9564-2871
Dunn, Erin C. https://orcid.org/0000-0003-1413-3229
Koenen, Karestan C.
Smoller, Jordan W.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (T32MH017119, K24MH094614)
- License Information
-
More Information
Article History
Received: 6 October 2018
Revised: 14 May 2019
Accepted: 21 May 2019
First Online: 24 July 2019
Compliance with ethical standards
:
: Dr Choi, Dr Dunn, and Dr Koenen have no conflicts of interest to disclose. Dr Stein has in the past 3 years been a consultant for Actelion, Aptinyx, Dart Neuroscience, Healthcare Management Technologies, Janssen, Neurocrine Biosciences, Oxeia Biopharmaceuticals, Pfizer, and Resilience Therapeutics. Dr Stein owns founders shares and stock options in Resilience Therapeutics and has stock options in Oxeia Biopharmaceticals. Dr Smoller is an unpaid member of the Bipolar/Depression Research Community Advisory Panel of 23andMe.
